Malaria is one of the leading causes of death among children in Uganda. Two of every 10 children who are admitted to hospitals succumb to the disease. Despite Uganda changing its malaria treatment policy from chroloquine to artemisinin-based combinations, there is still delayed parasite clearance among patients taking Coartem. In his postdoctoral fellowship under NURTURE program, Dr. Moses Ocan, a senior lecturer at the Department of Pharmacology and Therapeutics, Makerere University sought to assess the status of Artemisinin efficacy in the country. He also sought to determine whether there is sensitivity reemergence to Chloroquine among plasmodium parasites after more than a decade later when chloroquine was scrapped as a malaria treatment. Find out more about his discoveries by watching this video.

свернуть